Though India has built a robust domestic biosimilar market, its international presence and the ability to lower prices as compared to small molecule generics remain limited.
Without widespread access to biosimilars, thousands of cancer patients are losing their battle. Life-saving treatment is not a privilege but a right. The government should understand this.
With eye on rural votebank, Telangana budget raises allocations for farmers, power & welfare schemes, while introducing new initiatives and relying on borrowings to fund growth.
Rating democracies is a tricky business. I am only using the simple metric of who in the Indian subcontinent has had the most peaceful, stable, normal political transitions and continuity.
COMMENTS